Iovance Biotherapeutics, Inc.
IOVA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $115,694 | $114,888 | $231,731 | $78,229 |
| Short-Term Investments | $208,087 | $164,979 | $240,114 | $426,181 |
| Receivables | $69,340 | $151 | $0 | $0 |
| Inventory | $51,520 | $10,372 | $0 | $0 |
| Other Curr. Assets | $12,377 | $17,458 | $7,271 | $3,546 |
| Total Curr. Assets | $457,018 | $307,848 | $479,116 | $507,956 |
| Property Plant & Equip (Net) | $164,282 | $176,545 | $178,247 | $169,921 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $282,398 | $229,258 | $0 | $0 |
| Long-Term Investments | $0 | $66,430 | $0 | $91,588 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6,728 | $270 | $6,619 | $7,868 |
| Total NC Assets | $453,408 | $472,503 | $184,866 | $269,377 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $910,426 | $780,351 | $663,982 | $777,333 |
| Liabilities | – | – | – | – |
| Payables | $27,509 | $33,123 | $26,603 | $27,377 |
| Short-Term Debt | $12,896 | $7,777 | $12,587 | $5,057 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $81,936 | $69,406 | $52,295 | $56,766 |
| Total Curr. Liab. | $122,341 | $110,306 | $91,485 | $89,200 |
| LT Debt | $45,365 | $68,085 | $72,859 | $66,474 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $32,315 | $17,347 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $77,680 | $85,432 | $72,859 | $66,474 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $57,261 | $74,862 | $84,446 | $70,531 |
| Total Liabilities | $200,021 | $195,738 | $164,344 | $155,674 |
| Equity | – | – | – | – |
| Pref Stock | $3 | $3 | $3 | $3 |
| Common Stock | $13 | $11 | $8 | $7 |
| Retained Earnings | -$2,384,552 | -$2,012,375 | -$1,568,338 | -$1,172,445 |
| AOCI | -$1,046 | $2,526 | -$902 | -$601 |
| Other Equity | $3,095,987 | $2,594,448 | $2,068,867 | $1,794,695 |
| Total Equity | $710,405 | $584,613 | $499,638 | $621,659 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $910,426 | $780,351 | $663,982 | $777,333 |
| Net Debt | -$57,433 | -$39,026 | -$146,285 | -$6,698 |